ESRRB and neoplasm: Several mechanisms have been proposed for ESRRB’s tumor-suppressive effects, including the induction of cancer cell apoptosis, arrest of cell proliferation in the G1 phase, and inhibition of epithelial–mesenchymal transition (EMT).